type here...

CATEGORIES

Press Release

LATEST

1...789...12Page 8 of 12

TRENDING

EDITORS CHOICE

Reblozyl (luspatercept) Approved for Treatment of Transfusion-Dependent Anemia

Medika Life -
European Commission Approves Reblozyl (luspatercept) for the Treatment of Transfusion-Dependent Anemia in Adult Patients with Myelodysplastic Syndromes or Beta Thalassemia

Texas Food Relief with NCS Group and #BStrong Initiative Deliver Food Aid Across Texas

Medika Life -
Each NCS Group Unlimited Carrier Fleet Vehicle brings a total of $180K+ worth of supplies and aid, and a total of six trucks are arriving in Texas

Global Empowerment Mission in Partnership with Bethenny Frankel’s BStrong Initiative Align with NCS Group for Texas Aid Relief During The State of Emergency

Medika Life -
The LATEST mission is bringing three relief trucks to Texas with the first truck en route from Miami to Denton (The Cross Timbers Hope Center In Denton, TX) followed by Houston, TX on Tuesday (February 23)

Genome Editing and Cellular Therapies Show Promise for Treating Blood Disorders, Cancers

Medika Life -
Three studies report promising results in the use of cutting-edge genome editing and cellular therapies for hard-to-treat blood disorders and cancers.

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories